Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs
05:36am, Wednesday, 24'th Jan 2024
Integrating artificial intelligence and biotechnology could make 2024 a landmark year. The utilization of AI, machine learning and big data is nowadays a part of research and development (R&D) procedu
Maximizing Tax Deductions: 3 Charity-Friendly Stocks to Consider
01:29pm, Tuesday, 23'rd Jan 2024
Adopting charity-friendly stocks has emerged as a prominent trend in astute investing for those who wish to combine their financial goals with altruistic principles. This creative approach offers oppo
Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline
11:08am, Tuesday, 23'rd Jan 2024
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why I'm Avoiding 6%-Yielding Pfizer Stock
07:15am, Tuesday, 23'rd Jan 2024
Pfizer stock is popular among dividend growth investors due to its 14-year dividend growth streak and 6% yield. The company has strong underlying fundamentals, including an A credit rating from S&P an
Better Bull Market Buy: Pfizer vs. Moderna
06:49am, Saturday, 20'th Jan 2024
Pfizer is completing its biggest string of product launches ever, which should spur a new era of growth. Moderna expects to soon have a new RSV vaccine on the market, with other products to follow.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
10:06am, Friday, 19'th Jan 2024
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 No-Brainer Stocks to Buy Right Now for Less than $50
05:50am, Friday, 19'th Jan 2024
Brookfield Infrastructure's asset management strategy positions it well for growth. Enterprise Products Partners' hefty distribution makes the stock an attractive pick.
Pfizer: CEO Bets His Pension On The Stock - Upgrading To Buy
05:59am, Thursday, 18'th Jan 2024
Last November, I found Pfizer cheaply valued, but I failed to identify a catalyst that could drive PFE stock higher in the foreseeable future. Pfizer's priorities are changing today, with the CEO pled
Pfizer Dividend Yield Pushes Past 6%
03:33pm, Wednesday, 17'th Jan 2024
In trading on Wednesday, shares of Pfizer (NYSE:PFE) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.68), with the stock changing hands as low as $27.93 on the day. D
Pfizer Dividend Yield Pushes Past 6%
03:33pm, Wednesday, 17'th Jan 2024
In trading on Wednesday, shares of Pfizer (NYSE:PFE) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.68), with the stock changing hands as low as $27.93 on the day. D
Buy 4 January Dividend Fortune 500 Industry Leaders (Of 68), Watch 4 More
03:29pm, Wednesday, 17'th Jan 2024
The Summer 2023 edition of Fortune Magazine revealed 500 biggest U.S. companies by-revenue. Dogcatcher's quest to sniff-out the best-dividend buys focused on 68 industry-leaders using YCharts 1/12/24
Pfizer (PFE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:48pm, Tuesday, 16'th Jan 2024
In the closing of the recent trading day, Pfizer (PFE) stood at $28.32, denoting a -1.32% change from the preceding trading day.
Pfizer's Bourla Sinks His Pension Into Company Stock as CEO Defends Drug Firm
08:00am, Tuesday, 16'th Jan 2024
Albert Bourla told Barron's Andy Serwer that he's "all in" on Pfizer stock. He wants investors to believe.
I'm Passing on Pfizer Stock in 2024. Here's Why.
07:25am, Monday, 15'th Jan 2024
Pfizer enjoyed huge financial gains thanks to its breakthrough products to combat COVID-19. 2023 was a different story, however, as demand for its COVID vaccines stalled.
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
08:12am, Sunday, 14'th Jan 2024
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.
